Stock Market Today — Thursday, April 30, 2026
Your morning market intelligence for Thursday, April 30, 2026
Global markets are bracing for volatility this Thursday as geopolitical tensions escalate, particularly concerning the Middle East, while domestic economic signals remain mixed. Inflation concerns are resurfacing, potentially forcing the Federal Reserve's hand, even as AI continues to drive significant market interest and valuations. The energy sector is under particular scrutiny following recent developments.
Anthropic, an AI startup, is reportedly seeking a valuation of $900 billion, underscoring the intense investor appetite for artificial intelligence. This valuation, if achieved, would solidify AI's position as a dominant force shaping future technological and economic landscapes. Meanwhile, Alphabet (GOOGL, GOOG) delivered a strong quarter, with its results signaling that AI dominance is still in its nascent stages, further fueling optimism in the tech sector.
The Federal Reserve's path forward is becoming less clear, with recent dissents among policymakers raising doubts about the timing and likelihood of imminent rate cuts. This uncertainty comes as inflation indicators are nearing a "red zone," prompting increased speculation about potential Fed rate hikes and their broader market impact.
Geopolitical risks are intensifying, with the United Arab Emirates reportedly considering an exit from OPEC, a move that would significantly reshape the global oil market. This development, coupled with the potential for military action concerning Iran, has already sent oil prices surging to a four-year high, threatening global economic stability and stoking inflation fears, particularly in Asia. An "Iran War" scenario is also raising concerns about a helium shock, which could jeopardize global chip supply chains.
Eli Lilly (LLY) continues its strong performance, with its stock soaring after reporting a doubling of GLP-1 drug sales. This robust growth in its tirzepatide franchise, including Mounjaro and Zepbound, highlights the pharmaceutical giant's significant momentum and its impact on the healthcare sector.
What to Watch: Geopolitical headlines, especially those related to the Middle East and oil supply, will be paramount today. Investors will also be closely monitoring any further statements or data concerning inflation and the Federal Reserve's monetary policy outlook. Finally, the ongoing momentum in the AI sector, particularly around valuations and earnings, will continue to draw significant attention.
Affiliate disclosure — We may earn a commission if you subscribe via the link below, at no cost to you.
Access independent analyst ratings, fair value estimates, and portfolio tools trusted by over 30 million investors. The same data institutional managers use — now available to individual investors.
Start your free trial →Ian Gross is the founder and chief editor of The Big Market Report. With over a decade of equity research, he writes analysis that cuts through the noise to explain the "why" behind every major market move.
More by Ian →Never miss an analysis
